Effect of Omalizumab Therapy on Coagulation Parameters and Total Immunoglobulin E Levels in Patients with Chronic Idiopathic Urticaria and Bullous Pemphigoid

İncel Uysal P., Hayran Y., AKDOĞAN N., ÖKTEM A., Uğur Atılan A., GÜR AKSOY G., ...Daha Fazla

TURK DERMATOLOJI DERGISI, cilt.12, ss.159-166, 2018 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12
  • Basım Tarihi: 2018
  • Doi Numarası: 10.4274/tdd.3668
  • Dergi Adı: TURK DERMATOLOJI DERGISI
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.159-166
  • Anahtar Kelimeler: Anti-immunoglobulin E therapy, bullous pemphigoid, chronic urticaria, coagulation parameters, immunoglobulin E, omalizumab, DIMER PLASMA-LEVELS, BLOOD-COAGULATION, CLINICAL-RESPONSE, IGE, INFLAMMATION, AUTOIMMUNITY, ACTIVATION, DISEASE, MARKERS
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: The aim of this study is to assess the impact of omalizumab on coagulation biomarkers and immunoglobulin E (IgE) levels in chronic idiopathic urticaria/chronic spontaneous urticaria (CIU/CSU) and bullous pemphigoid (BP) patients.